Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sandy Beare
Observed names:
S Beare,
S. Beare
Institutions:
King's College London,
Cancer Research UK
Observed institutions:
King's College London,
Queen's University,
Leicester Royal Infirmary,
Cancer Research UK,
Freeman Hospital,
Canadian Cancer Trials Group,
University College London,
Birkbeck, University of London
show all 8
ORCID:
0000-0002-9055-1804
Observed ORCID:
0000-0002-9055-1804
OpenAlex ID:
A5000643578
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
2012
·
Ujjal Mallick
, Clive Harmer
, et al.
·
New England Journal of Medicine
·
648
PDF
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
2017
·
Beatrice Seddon
, Sandra J Strauss
, et al.
·
The Lancet Oncology
·
575
PDF
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
2013
·
J.W. Valle
, J. Furuse
, et al.
·
Annals of Oncology
·
425
PDF
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
2015
·
Juan W Valle
, Harpreet Wasan
, et al.
·
The Lancet Oncology
·
294
PDF
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
2017
·
Robert Glynne-Jones
, David Sebag-Montefiore
, et al.
·
The Lancet Oncology
·
201
PDF
Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.
1998
·
P Hoskins
, E Eisenhauer
, et al.
·
Journal of Clinical Oncology
·
171
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
2013
·
T Meyer
, A Kirkwood
, et al.
·
British Journal of Cancer
·
153
PDF
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial
2019
·
Peter J. Hoskin
, Kirsten Hopkins
, et al.
·
JAMA
·
128
PDF
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial
2019
·
Stuart A Taylor
, Sue Mallett
, et al.
·
The Lancet. Gastroenterology & hepatology
·
82
PDF
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer
2002
·
K J O'Byrne
, A L Thomas
, et al.
·
British Journal of Cancer
·
80
PDF
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial
2019
·
Stuart A Taylor
, Sue Mallett
, et al.
·
The Lancet Respiratory Medicine
·
79
PDF
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
2019
·
Stuart A Taylor
, Susan Mallett
, et al.
·
Health Technology Assessment
·
73
PDF
Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial
2014
·
R. Glynne-Jones
, L. Kadalayil
, et al.
·
Annals of Oncology
·
59
PDF
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer.
2018
·
Stephen P Pereira
, Mark Jitlal
, et al.
·
PubMed Central
·
58
PDF
SCORAD III: Randomized noninferiority phase III trial of single-dose radiotherapy (RT) compared to multifraction RT in patients (pts) with metastatic spinal canal compression (SCC).
2017
·
Peter Hoskin
, Vivek Misra
, et al.
·
Journal of Clinical Oncology
·
46
Phase I trial of sequential topotecan followed by etoposide in adults with myeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study
1999
·
M Crump
, J Lipton
, et al.
·
Leukemia
·
42
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
2015
·
for the Bacchus investigators
, R. Glynne-Jones
, et al.
·
BMC Cancer
·
34
PDF
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)
2018
·
R. Glynne-Jones
, M.R. Hall
, et al.
·
Heliyon
·
31
PDF
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
2018
·
Alison C. Backen
, Andre Lopes
, et al.
·
British Journal of Cancer
·
27
PDF
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)
2017
·
Stuart A. Taylor
, Sue Mallett
, et al.
·
BMC Cancer
·
27
PDF
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment
2019
·
on behalf of the STREAMLINE investigators
, Anne Miles
, et al.
·
European Radiology
·
26
PDF
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
2017
·
Simon Gollins
, Nick West
, et al.
·
British Journal of Cancer
·
26
PDF
SCORAD III: Randomized noninferiority phase III trial of single-dose radiotherapy (RT) compared to multifraction RT in patients (pts) with metastatic spinal canal compression (SCC).
2017
·
Peter Hoskin
, Vivek Misra
, et al.
·
Journal of Clinical Oncology
·
26
Predictors of patient preference for either whole body magnetic resonance imaging (WB‐MRI) or CT/ PET‐CT for staging colorectal or lung cancer
2020
·
Anne Miles
, Ruth EC Evans
, et al.
·
Journal of Medical Imaging and Radiation Oncology
·
16
PDF
Survival and safety post study treatment completion: an updated analysis of the Intergroup Exemestane Study (IES) – submitted on behalf of the IES Investigators
2009
·
R. Coombes
, L. Kilburn
, et al.
·
European Journal of Cancer Supplements
·
10
Show more works
View as search
Works count:
45
Citation count:
3,398
H-index:
23
I10-index:
25
Year
Topic
Type